81 POSTER Preclinical pharmacodynamic markers of MGCD265, a potent orally active c-Met/VEGFR multitargeted kinase inhibitor in Phase I clinical trials
N. Beaulieu; I. Dupont; C. Beaulieu; H. Nguyen; H. Ste-Croix; S. Claridge; L. Isakovic; A. Vaisburg; J.M. Besterman; C. Maroun
- 作者N. Beaulieu; I. Dupont; C. Beaulieu; H. Nguyen; H. Ste-Croix; S. Claridge; L. Isakovic; A. Vaisburg; J.M. Besterman; C. Maroun
- 卷第6卷
- 期第12期
- 文件大小61.56KB
- 发表时间2008
- DOI10.1016/s1359-6349(08)72013-5